These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39026319)

  • 21. Clinical significance of granule-containing myeloma cells in patients with newly diagnosed multiple myeloma.
    Suzuki K; Yano S; Nishiwaki K; Sano K; Shimada T; Yahagi Y; Ogasawara Y; Sugiyama K; Takahara S; Saito T; Kasama K; Minami J; Yokoyama H; Kamiyama Y; Katsube A; Masuoka H; Katori M; Machishima T; Ouchi A; Dobashi N; Kaito K; Usui N; Aiba K
    Cancer Med; 2016 Nov; 5(11):3051-3058. PubMed ID: 27734595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
    Danziger SA; McConnell M; Gockley J; Young MH; Rosenthal A; Schmitz F; Reiss DJ; Farmer P; Alapat DV; Singh A; Ashby C; Bauer M; Ren Y; Smith K; Couto SS; van Rhee F; Davies F; Zangari M; Petty N; Orlowski RZ; Dhodapkar MV; Copeland WB; Fox B; Hoering A; Fitch A; Newhall K; Barlogie B; Trotter MWB; Hershberg RM; Walker BA; Dervan AP; Ratushny AV; Morgan GJ
    PLoS Med; 2020 Nov; 17(11):e1003323. PubMed ID: 33147277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk groups of myeloma patients by histologic pattern and proliferative activity.
    Pich A; Chiusa L; Marmont F; Navone R
    Am J Surg Pathol; 1997 Mar; 21(3):339-47. PubMed ID: 9060605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis.
    Bao L; Wang YT; Lu MQ; Chu B; Shi L; Gao S; Fang LJ; Xiang QQ; Ding YH; Liu X; Zhao X; Wang MZ; Chen Y; Hu WK
    Front Endocrinol (Lausanne); 2023; 14():1157969. PubMed ID: 37181039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and Clinical Significance of NAMPT in Bone Marrow of Patients with Multiple Myeloma].
    Wang YR; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1739-1744. PubMed ID: 38071054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
    Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
    Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging findings and clinical features of patients with multiple myeloma with the prognostic effect of bone marrow focal and diffuse infiltration patterns on spine MRI.
    Aribas BK; Arda K; Yologlu Z; Ciledag N; Aktas E; Ozdemir S; Dogan K; Fen T; Dagli M
    Minerva Med; 2011 Apr; 102(2):115-24. PubMed ID: 21483398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predictive Value of Pre-treatment Serum Uric Acid Level for Prognosis in Newly Diagnosed Patients with Multiple Myeloma].
    Xu SQ; Zhao P; Wang ZH; Deng H; Zhang L; Wei J; Zou XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1216-1223. PubMed ID: 34362505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Myeloma with Advanced Bone Disease and Low Tumor Burden - Different Clinical Presentation but Similar Outcome after Bortezomib-Based Therapy and Radiotherapy.
    Goranova-Marinova V; Yaneva M; Deneva T; Goranov S; Mužina Mišić D
    Acta Clin Croat; 2017 Jun; 56(2):262-269. PubMed ID: 29485793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis.
    Vener C; Fracchiolla NS; Gianelli U; Calori R; Radaelli F; Iurlo A; Caberlon S; Gerli G; Boiocchi L; Deliliers GL
    Blood; 2008 Feb; 111(4):1862-5. PubMed ID: 18029552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance.
    Lazzarino M; Morra E; Castello A; Inverardi D; Coci A; Pagnucco G; Magrini U; Zei G; Bernasconi C
    Br J Haematol; 1986 Oct; 64(2):227-40. PubMed ID: 3465364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myc rearrangement redefines the stratification of high-risk multiple myeloma.
    Jin X; Li H; Zhang D; Liu S; Song Y; Zhang F; Li Z; Zhuang J
    Cancer Med; 2024 Jun; 13(11):e7194. PubMed ID: 38845529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.
    Korde N; Roschewski M; Zingone A; Kwok M; Manasanch EE; Bhutani M; Tageja N; Kazandjian D; Mailankody S; Wu P; Morrison C; Costello R; Zhang Y; Burton D; Mulquin M; Zuchlinski D; Lamping L; Carpenter A; Wall Y; Carter G; Cunningham SC; Gounden V; Sissung TM; Peer C; Maric I; Calvo KR; Braylan R; Yuan C; Stetler-Stevenson M; Arthur DC; Kong KA; Weng L; Faham M; Lindenberg L; Kurdziel K; Choyke P; Steinberg SM; Figg W; Landgren O
    JAMA Oncol; 2015 Sep; 1(6):746-54. PubMed ID: 26181891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.
    Riccardi A; Ucci G; Luoni R; Castello A; Coci A; Magrini U; Ascari E
    J Clin Pathol; 1990 Jun; 43(6):469-75. PubMed ID: 2199532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma.
    Zhang L; Chen S; Huang M; Wang W; Liang Y; Wang Y
    Ann Hematol; 2023 Jan; 102(1):125-132. PubMed ID: 36441260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.
    Stork M; Sevcikova S; Jelinek T; Minarik J; Radocha J; Pika T; Pospisilova L; Spicka I; Straub J; Pavlicek P; Jungova A; Knechtova Z; Sandecka V; Maisnar V; Hajek R; Pour L
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.
    Buesche G; Georgii A; Kreipe HH
    Histopathology; 2006 Jan; 48(2):133-48. PubMed ID: 16405662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelopoietic effect of bone marrow fibroblasts cultured from patients with myelofibrosis.
    Wang JC
    Am J Hematol; 1988 Apr; 27(4):235-41. PubMed ID: 3258473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical importance of routine paraffin-embedded bone marrow biopsy in multiple myeloma.
    Carbone A; Manconi R; Sulfaro S; Vaccher E; Zagonel V; Poletti A; Volpe R; Tirelli U; Monfardini S
    Tumori; 1987 Jun; 73(3):315-9. PubMed ID: 3603727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.